Regulators are modernizing their expectations, and it's become clear that validation can no longer function as a point-in-time event.

As new consumer hardware and software capabilities have bumped up against medicine over the last few years, consumers and manufacturers alike have struggled with identifying the line between “wellness ...

The USFDA further highlighted deficiencies in environmental monitoring in manufacturing areas, indicating gaps in ensuring ...

Clinical trials are full of moving parts and, despite recent technological advances, they still come with manual processes ...

After seven years and $30 million invested in clinical AI research, CEO Grace Chang reveals the steep economics of building healthcare AI as Kintsugi shuts down.

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Some say we’ve entered a new age of AI-enabled scientific discovery. But human insight and creativity still can’t be ...

As it stands, the pharmaceutical industry faces a significant technical bottleneck: only 10% of R&D ends in an approved medicine.

News: BioAI at India AI Impact Summit outlined how AI+biology can accelerate biomanufacturing—using genomics, in-silico design, and data loops for scale and trust.

King's College London today announced the launch of VISI-ON-BRAIN (Cutting-edge Human In Vitro and In Silico Biomedical Tools on Brain Disorders), a ...

According to Valuates Reports, The global market for AI in Biotechnology was valued at USD 1033 Million in the year 2024 and is projected to reach a revised size of USD 1971 Million by 2031, growing ...

XINGTAI CITY, HEBEI PROVINCE, CHINA, February 10, 2026 /EINPresswire.com/ -- Sealing technology has become increasingly ...